반응식
C(O[C:6]([NH:8][C:9]([CH2:17]O)([CH2:13][CH:14]([CH3:16])[CH3:15])[C:10]([OH:12])=O)=[O:7])(C)(C)C.[NH2:19][CH2:20][C:21]12[CH2:30][CH:25]3[CH2:26][CH:27]([CH2:29][CH:23]([CH2:24]3)[CH2:22]1)[CH2:28]2>>[C:21]12([CH2:20][N:19]3[CH2:17][C:9]([CH2:10][OH:12])([CH2:13][CH:14]([CH3:15])[CH3:16])[NH:8][C:6]3=[O:7])[CH2:28][CH:27]3[CH2:26][CH:25]([CH2:24][CH:23]([CH2:29]3)[CH2:22]1)[CH2:30]2참가 물질
3
실험 절차
The title compound was prepared following procedures analogous to those described in Example 27 using (±)-2-(tert-butoxycarbonylamino)-2-(hydroxymethyl)-4-methylpentanoic acid and 1-(aminomethyl)adamantane. MS m/z=321.
출처 및 근거
- ORD 기록
- ord-be24594330af48f5870c8035a084a492
- 출처 데이터셋
- uspto-grants-2014_09
- 특허 번호
- US08835426B2
연결된 노트
불러오는 중…